Diabetes is increasing in France. According InVs who conducted a study based on reimbursement data of 56.5 million people in the general scheme, in 2007 diabetes affects 2.5 million French Extracts from the report
prevalence treated diabetes increased from 2.7 to 3.6% between 2000 and 2005 the population residing in metropolitan France and protected by the general scheme or an average annual increase of 5.7%.
This growth is related to the increase of overweight and obesity, an aging population, improving the life expectancy of people treated for diabetes and increased screening. Forecasts based on 1999 data and all health insurance schemes have led to estimates by 2016 the population of 2.8 million people with diabetes, a prevalence of about 4.5%.
The frequency of diabetes in France is characterized by its high increase, but also by geographical disparities. These are found in several studies with different sources. High prevalences are found in regions overseas, in the north and north-east of metropolitan France and Seine-Saint-Denis. Conversely, the Great West, to some extent, seems relatively preserved.
This geography is also correlated with obesity. This study aims to update prevalence data of diabetes treated in France and to measure geographical differences observing the recent evolutionary trends at the departmental level.
Results: A prevalence of treated diabetes who reached 3.95% in 2007. In 2007, the prevalence of diabetes treated in the general scheme was 3.65%. Extrapolated to the population all schemes (INSEE population 1/1/2008), the rate in 2007 was 3.95%, corresponding to 2.5 million people treated for diabetes (3.78% in 2006 and 2 4 million). Over a quarter (25.1%) of people treated for diabetes in 2007 had used insulin, alone or in combination with oral antidiabetics. People with diabetes were supported by health insurance in long-term illness (all combined ALD) in 83.2% of cases. An excess risk of diabetes by 45% for men after 40 years: nearly one in five men with diabetes at age 75
In 2007, people treated for diabetes had a mean age of 64.8 years (SD: 13.8 years). Analysis of prevalence by age showed significant differences by age: 0-44 years (0.4%), and 45 years and over maximum prevalence Diabetes was achieved for 75-79 years, with 18.2% for males of people treated for diabetes and 13.2% for women (Figure 1). For children and adolescents 0-14 years the prevalence of treated diabetes, both sexes combined, was 0.8 per 1000.
Read the full report
Source
Institut de Veille Sanitaire
